A detailed history of Provence Wealth Management Group transactions in Amgen Inc stock. As of the latest transaction made, Provence Wealth Management Group holds 1,445 shares of AMGN stock, worth $404,614. This represents 0.22% of its overall portfolio holdings.

Number of Shares
1,445
Previous 1,291 11.93%
Holding current value
$404,614
Previous $346,000 20.23%
% of portfolio
0.22%
Previous 0.21%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

BUY
$255.7 - $288.46 $39,377 - $44,422
154 Added 11.93%
1,445 $416,000
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $20,115 - $24,974
-92 Reduced 6.65%
1,291 $346,000
Q2 2023

Jul 24, 2023

BUY
$214.27 - $253.37 $73,494 - $86,905
343 Added 32.98%
1,383 $307,000
Q1 2023

Apr 26, 2023

BUY
$225.79 - $275.2 $53,738 - $65,497
238 Added 29.68%
1,040 $251,000
Q4 2022

Feb 02, 2023

BUY
$229.03 - $291.01 $183,682 - $233,390
802 New
802 $210,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Provence Wealth Management Group Portfolio

Follow Provence Wealth Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Provence Wealth Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Provence Wealth Management Group with notifications on news.